PATENT CLAIM ANALYSIS

Application Number: 15945601
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "729000"]

Abstract:
The present invention relates to a pharmaceutical composition for preventing or treating autoimmune diseases having cedrol or a pharmaceutically acceptable salt thereof as an active ingredient. Particularly, the cedrol or the derivative thereof of the present invention inhibits the expression of IL-17A, and in particular, cedrol, cedryl acetate, and cedrene exhibit the effect of delaying the outbreak of psoriasis and treating thereof in a psoriasis animal model. Therefore, these compounds can be used for the treatment of autoimmune diseases mediated by IL-17.

Claim (Index 3):
The method of alleviating skin irritation according to  claim 2 , wherein the autoimmune disease is mediated by interleukin-17.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 91.0
- Lexical Diversity: 1.625
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15945606', '15545427', '15258263', '14369467', '15680449']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7703111248211066
- 35 USC 102 Novelty (BERT): 0.6103434388916549
- Combined Prediction Score: 0.7543143562281615
- Mean Citation Score: 323.80314
- Max Citation Score: 676.56506
- Similarity Product: 450.2127028484774

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test